(MedPage Today) — The FDA approved labeling changes for elivaldogene autotemcel (eli-cel; Skysona), a one-time gene therapy for patients with early, active cerebral adrenoleukodystrophy (CALD), to reflect new safety information about hematologic…
Source link : https://www.medpagetoday.com/neurology/generalneurology/116922
Author :
Publish date : 2025-08-08 21:27:00
Copyright for syndicated content belongs to the linked Source.
